z-logo
Premium
Synthesis of racemic and enantiomerically pure 2′‐thia‐2′,3′‐dideoxycytidine as potential anti‐hepatitis B virus agents
Author(s) -
Pan BaiChuan,
Cheng YungChi,
Chu ShihHsi
Publication year - 1997
Publication title -
journal of heterocyclic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.321
H-Index - 59
eISSN - 1943-5193
pISSN - 0022-152X
DOI - 10.1002/jhet.5570340330
Subject(s) - chemistry , stereochemistry , hepatitis b virus , virus , virology , biology
A novel class of nucleosides with the C 1 , atom bonded to three hetero atoms was synthesized. 2′‐Thia‐2′,3′‐dideoxycytidine was the pilot compound of this series. (±)‐β‐2′‐Thia‐1′,3′‐dideoxycytidine ( 6 ) and (±)‐α‐2′‐thia‐2′,3′‐dideoxycytidine ( 7 ) were synthesized from (±)‐3‐mercapto‐1,2‐propanediol. The synthesis of the enantiomerically pure 2′‐thia‐2′,3′‐dideoxycytidines (α‐D‐form, β‐D‐form, α‐1‐form and β‐L‐form) from optically pure ( S )‐(2,2‐dimethyl‐1,3‐dioxalan‐yl)methyl p ‐toluenesulfonate ( 8 ) and its ( R )‐isomer 18 was also described. The preliminary biological results showed that (+)‐β‐D‐2′‐thia‐2′,3′‐dideoxycytidine ( 26 ) was the most active against human hepatitis B virus with an ED 50 of 3 μ M .

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom